Friday, November 19, 2021
Print Current Session:
|
|
Friday
SESSION 96:
STRATEGIES FOR THROMBOEMBOLIC EVENTS IN THE VENOUS SYSTEM
Location: LECTURE HALL 3 - WALDORF ASTORIA GRAND BALLROOM A
Moderators:Michael K.W. Lichtenberg, MD / Brian G. DeRubertis, MD |
|
SESSION 96 SCHEDULE | |
VTE INTERVENTIONAL | |
1:16 PM - 1:21 PM | Thrombolysis For Acute DVT: Utilization And Guidance From Current Clinical Trials |
Presenter(s):Brian G. DeRubertis, MD Location: LECTURE HALL 3 - WALDORF ASTORIA GRAND BALLROOM A |
|
View Slides in PDF | |
1:22 PM - 1:27 PM | Venous Aneurysms: Should They Be Treated |
Presenter(s):Peter F. Lawrence, MD Location: LECTURE HALL 3 - WALDORF ASTORIA GRAND BALLROOM A |
|
View Slides in PDF | |
1:28 PM - 1:33 PM | DVT Removal Without Thrombolytics – Mechanical Thrombectomy Is Now The Standard Of Care For Both Upper And Lower Extremity DVT |
Presenter(s):Patrick E. Muck, MD, FACS Location: LECTURE HALL 3 - WALDORF ASTORIA GRAND BALLROOM A |
|
View Slides in PDF | |
1:34 PM - 1:39 PM | P-Max Study: Mechanical Thrombectomy For Iliofemoral DVT With Aspirex |
Presenter(s):Michael K.W. Lichtenberg, MD Location: LECTURE HALL 3 - WALDORF ASTORIA GRAND BALLROOM A |
|
View Slides in PDF | |
1:40 PM - 1:45 PM | Panel Discussion |
1:46 PM - 2:21 PM | Break - Visit Exhibits And Pavilions (North, West, Center and South Foyers) |
CENTRAL VENOUS THROMBOSIS; COVID-19; VTE MEDICAL | |
Moderator(s): Steve Elias, MD / Mikel Sadek, MD | |
2:22 PM - 2:27 PM | COVID-19 Treatment Of Venous Thrombosis In Hospitalized Patients |
Presenter(s):Mikel Sadek, MD Location: LECTURE HALL 3 - WALDORF ASTORIA GRAND BALLROOM A |
|
View Slides in PDF | |
2:28 PM - 2:33 PM | COVID-19 Outpatient Experience With Anticoagulation |
Presenter(s):Steve Elias, MD Location: LECTURE HALL 3 - WALDORF ASTORIA GRAND BALLROOM A |
|
View Slides in PDF | |
2:34 PM - 2:39 PM | Closed Plication Is A Safe And Effective Method For Treating Popliteal Venous Aneurysm |
Presenter(s):Thomas W. Wakefield, MD Location: LECTURE HALL 3 - WALDORF ASTORIA GRAND BALLROOM A |
|
View Slides in PDF | |
2:40 PM - 2:45 PM | Mesenteric Vein Thrombosis: What Is The Best Strategy |
Presenter(s):Mark G. Davies, MD Location: LECTURE HALL 3 - WALDORF ASTORIA GRAND BALLROOM A |
|
View Slides in PDF | |
2:46 PM - 2:51 PM | DOAC Revolution – Which Drug For What Disease: Review Of Ongoing Trials |
Presenter(s):Andrea T. Obi, MD Location: LECTURE HALL 3 - WALDORF ASTORIA GRAND BALLROOM A |
|
View Slides in PDF | |
2:52 PM - 2:57 PM | Update In Experimental DVT Pathogenesis And Resolution |
Presenter(s):Peter Henke, MD Location: LECTURE HALL 3 - WALDORF ASTORIA GRAND BALLROOM A |
|
View Slides in PDF | |
2:58 PM - 3:03 PM | Inflammation And Venous Thrombosis: An Evidence Summary |
Presenter(s):Thomas W. Wakefield, MD Location: LECTURE HALL 3 - WALDORF ASTORIA GRAND BALLROOM A |
|
View Slides in PDF | |
3:04 PM - 3:09 PM | Pediatric DVT: An Evidence Summary |
Presenter(s):Dawn M. Coleman, MD Location: LECTURE HALL 3 - WALDORF ASTORIA GRAND BALLROOM A |
|
View Slides in PDF | |
3:10 PM - 3:15 PM | Using The Femoral Vein As A Tunneling Conduit For An Arterial Bypass: Venous Outcomes In PQ Bypass |
Presenter(s):Mark A. Adelman, MD Location: LECTURE HALL 3 - WALDORF ASTORIA GRAND BALLROOM A |
|
View Slides in PDF | |
3:16 PM - 3:21 PM | Duration Of Anticoagulation |
Presenter(s):Rachel Rosovsky, MD, MPH Location: LECTURE HALL 3 - WALDORF ASTORIA GRAND BALLROOM A |
|
View Slides in PDF | |
3:22 PM - 3:27 PM | Should All Patients With Acute VTE Be Treated With A Statin: When And Dose |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC Location: LECTURE HALL 3 - WALDORF ASTORIA GRAND BALLROOM A |
|
View Slides in PDF | |
3:28 PM - 3:33 PM | Update On Reversal Agents For The DOACs |
Presenter(s):Timothy K. Liem, MD, MBA Location: LECTURE HALL 3 - WALDORF ASTORIA GRAND BALLROOM A |
|
View Slides in PDF | |
3:34 PM - 3:39 PM | Role Of Thrombophilia Testing |
Presenter(s):Rachel Rosovsky, MD, MPH Location: LECTURE HALL 3 - WALDORF ASTORIA GRAND BALLROOM A |
|
View Slides in PDF | |
3:40 PM - 3:45 PM | Panel Discussion |
END OF SESSION 96 | |
previous | next |